JDRF T1D Fund: A NY-based non-profit accelerating type 1 diabetes treatments through early-stage investments.
Location
Boston, MA, US
Founded
2016
JDRF T1D Fund is a non-profit venture philanthropy organization focused on early-stage investments in type 1 diabetes (T1D) treatments, preventions, and cures. Based in New York, the fund targets innovative life sciences companies developing solutions for T1D, with investments spanning various stages from seed to Series D rounds.
The fund's portfolio includes notable companies such as Abata Therapeutics, Bigfoot Biomedical, and GentiBio. JDRF T1D Fund leverages its expertise in T1D research and treatment to support portfolio companies, aiming to accelerate the development of breakthrough therapies and technologies for the estimated 1.7 million people living with T1D globally.
Jdrf T1D Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
